Aberdeen Group
PRQR icon

Aberdeen Group’s ProQR Therapeutics PRQR Stock Holding History

Aberdeen Group’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.37M Buy
3,316,965
+366,289
+12% +$600K 0.01% 681
2025
Q4 		$5.96M Buy
2,950,676
+651,853
+28% +$1.52M 0.01% 678
2025
Q3 		$4.9M Buy
2,298,823
+448,475
+24% +$980K 0.01% 700
2025
Q2 		$3.77M Hold
1,850,348
– – 0.01% 732
2025
Q1 		$2.46M Buy
+1,850,348
New +$3.94M ﹤0.01% 745

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return